Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse

The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6)...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 36; no. 4; pp. 753 - 762
Main Authors Moyer, Robert A, Wang, Danxin, Papp, Audrey C, Smith, Ryan M, Duque, Linda, Mash, Deborah C, Sadee, Wolfgang
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.03.2011
Nature Publishing Group
Subjects
D2S
Online AccessGet full text

Cover

Loading…
Abstract The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p =0.001; OR=3.4 (1.7–7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.
AbstractList The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.
The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p =0.001; OR=3.4 (1.7–7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.
The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this relationship remain uncertain. DRD2 mRNA exists in two main splice isoforms with distinct functions: D2 long (D2L) and D2 short (D2S, lacking exon 6), expressed mainly postsynaptically and presynaptically, respectively. Two intronic single-nucleotide polymorphisms (SNPs rs2283265 (intron 5) and rs1076560 (intron 6)) in high linkage disequilibrium (LD) with each other have been reported to alter D2S/D2L splicing and several behavioral traits in human subjects, such as memory processing. To assess the role of DRD2 variants in cocaine abuse, we measured levels of D2S and D2L mRNA in human brain autopsy tissues (prefrontal cortex and putamen) obtained from cocaine abusers and controls, and genotyped a panel of DRD2 SNPs (119 abusers and 95 controls). Robust effects of rs2283265 and rs1076560 on reducing formation of D2S relative to D2L were confirmed. The minor alleles of rs2283265/rs1076560 were considerably more frequent in Caucasians (18%) compared with African Americans (7%). Also, in Caucasians, rs2283265/rs1076560 minor alleles were significantly overrepresented in cocaine abusers compared with controls (rs2283265: 25 to 9%, respectively; p=0.001; OR=3.4 (1.7-7.1)). Several SNPs previously implicated in diverse clinical association studies are in high LD with rs2283265/rs1076560 and could have served as surrogate markers. Our results confirm the role of rs2283265/rs1076560 in D2 alternative splicing and support a strong role in susceptibility to cocaine abuse.
Author Mash, Deborah C
Duque, Linda
Sadee, Wolfgang
Papp, Audrey C
Smith, Ryan M
Moyer, Robert A
Wang, Danxin
Author_xml – sequence: 1
  givenname: Robert A
  surname: Moyer
  fullname: Moyer, Robert A
  organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University
– sequence: 2
  givenname: Danxin
  surname: Wang
  fullname: Wang, Danxin
  organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University
– sequence: 3
  givenname: Audrey C
  surname: Papp
  fullname: Papp, Audrey C
  organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University
– sequence: 4
  givenname: Ryan M
  surname: Smith
  fullname: Smith, Ryan M
  organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University
– sequence: 5
  givenname: Linda
  surname: Duque
  fullname: Duque, Linda
  organization: Departments of Neurology and Molecular and Cellular Pharmacology, University of Miami School of Medicine
– sequence: 6
  givenname: Deborah C
  surname: Mash
  fullname: Mash, Deborah C
  organization: Departments of Neurology and Molecular and Cellular Pharmacology, University of Miami School of Medicine
– sequence: 7
  givenname: Wolfgang
  surname: Sadee
  fullname: Sadee, Wolfgang
  email: wolfgang.sadee@osumc.edu
  organization: Department of Pharmacology, Program in Pharmacogenomics, College of Medicine, The Ohio State University
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24037436$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21150907$$D View this record in MEDLINE/PubMed
BookMark eNqFkttrFDEUxoNU7Lb65rMEQXxxai6Ty74Iw1ZtoaB4gb6FbCazm5JJpslMpf-9GXZrtSi-JOTkdz7Od845AgchBgvAc4xOMKLybRiGE4LKiyD5CCywqFHFaX15ABZILmmFKb08BEc5XyGEmeDyCTgkGDO0RGIBpvMwphicgZ-jv-1jGrYu9xk2XWfN6MIGNn60KejR3Vj4dfDOzMHYwbOp1wGexkH3Llh4SuAXa-wwxgSbZGGTczROj7aFP9y4hato9Mw16ynbp-Bxp322z_b3Mfj-4f231Vl18enj-aq5qAzDaCw2JGOWUCsQMWtEUEu5JGvGDBVGGi011yVAlpKKlrN2bXXLMKlbQTTVgtJj8G6nO0zr3rbGFrPaqyG5XqdbFbVTf_4Et1WbeKMoYkxQUQRe7wVSvJ5sHlXvsrHe62DjlFXpIWa85vy_pGS4FpxzVsiXD8irOJUO-xkqemU2pEAvfq_8V8l3kyvAqz2gs9G-SzoYl--5GlFR07kusuNMijkn2ynjxjLNOBt2XmGk5jVSZY3UvEblkCXpzYOkO91_4NUOzwULG5vuHf2V_wn9MNgV
CODEN NEROEW
CitedBy_id crossref_primary_10_35118_apjmbb_2024_032_1_06
crossref_primary_10_1111_eci_12463
crossref_primary_10_1021_acschemneuro_2c00425
crossref_primary_10_1016_j_drugalcdep_2015_03_003
crossref_primary_10_1007_s00702_018_1946_5
crossref_primary_10_1097_FPC_0b013e328361c39d
crossref_primary_10_3390_ijerph17010365
crossref_primary_10_1038_tp_2015_176
crossref_primary_10_1371_journal_pgen_1007834
crossref_primary_10_1016_j_neuroimage_2019_06_036
crossref_primary_10_1186_s12991_018_0192_4
crossref_primary_10_1177_1933719117698582
crossref_primary_10_2217_pgs_11_23
crossref_primary_10_1016_j_neubiorev_2013_01_007
crossref_primary_10_1016_j_ygeno_2019_05_013
crossref_primary_10_2217_pgs_16_1
crossref_primary_10_1007_s12035_014_8826_2
crossref_primary_10_1016_j_forsciint_2020_110511
crossref_primary_10_1080_02640414_2015_1020841
crossref_primary_10_1002_mgg3_407
crossref_primary_10_1016_j_jpsychires_2017_03_005
crossref_primary_10_1016_j_jri_2015_04_001
crossref_primary_10_1111_adb_12489
crossref_primary_10_1186_s40246_017_0120_8
crossref_primary_10_2217_pme_2016_0100
crossref_primary_10_1172_JCI172886
crossref_primary_10_1007_s12041_018_0917_9
crossref_primary_10_1038_mp_2012_50
crossref_primary_10_7554_eLife_31924
crossref_primary_10_1093_hmg_ddv434
crossref_primary_10_1038_srep36993
crossref_primary_10_7554_eLife_09358
crossref_primary_10_1007_s12017_013_8224_3
crossref_primary_10_1007_s12035_019_1543_0
crossref_primary_10_1038_srep17996
crossref_primary_10_1016_j_pnpbp_2012_05_002
crossref_primary_10_1186_s12864_015_1749_0
crossref_primary_10_1002_mgg3_869
crossref_primary_10_1101_gr_268037_120
crossref_primary_10_1007_s10882_018_9590_4
crossref_primary_10_1038_tp_2012_146
crossref_primary_10_1016_j_phrs_2019_104283
crossref_primary_10_1038_s41598_017_10561_1
crossref_primary_10_1016_j_neubiorev_2021_08_016
crossref_primary_10_1016_j_ygeno_2014_11_009
crossref_primary_10_2217_pgs_13_58
crossref_primary_10_5483_BMBRep_2013_46_11_207
crossref_primary_10_1371_journal_pone_0072220
crossref_primary_10_1080_15622975_2017_1372630
crossref_primary_10_1186_s41021_015_0020_x
crossref_primary_10_1093_brain_aww109
crossref_primary_10_3389_fpsyt_2019_00626
crossref_primary_10_3390_ijerph19169955
crossref_primary_10_3390_genes13061045
crossref_primary_10_1038_s41380_018_0125_2
crossref_primary_10_1016_j_taap_2016_06_011
crossref_primary_10_1007_s13365_013_0204_8
crossref_primary_10_1074_jbc_M113_535203
crossref_primary_10_1016_j_gde_2025_102340
crossref_primary_10_1097_YPG_0000000000000258
crossref_primary_10_1080_08820139_2019_1569677
crossref_primary_10_3390_ijms241813816
crossref_primary_10_1016_j_repbre_2024_01_003
crossref_primary_10_1097_YPG_0000000000000095
crossref_primary_10_1097_FPC_0b013e32835ff536
crossref_primary_10_1016_j_ridd_2014_04_007
crossref_primary_10_1371_journal_pone_0050086
crossref_primary_10_1016_j_neubiorev_2023_105456
crossref_primary_10_1371_journal_pone_0080613
crossref_primary_10_1038_srep13090
crossref_primary_10_3390_ijms22073781
crossref_primary_10_2478_cpp_2022_0016
crossref_primary_10_1002_ajmg_b_32179
crossref_primary_10_1002_jps_23483
crossref_primary_10_1016_j_ygeno_2017_12_003
crossref_primary_10_1089_gtmb_2020_0011
crossref_primary_10_1016_j_pnpbp_2019_03_021
crossref_primary_10_1111_ahg_12104
crossref_primary_10_1186_s12993_016_0109_9
crossref_primary_10_1038_s41598_021_02715_z
crossref_primary_10_1016_j_neuron_2018_10_005
crossref_primary_10_1007_s13311_019_00828_y
crossref_primary_10_1016_j_tig_2013_07_006
crossref_primary_10_3390_jcm9113593
crossref_primary_10_5402_2012_972607
crossref_primary_10_3390_brainsci10050262
crossref_primary_10_1007_s00384_018_3097_4
crossref_primary_10_1080_15622975_2024_2366235
crossref_primary_10_1038_tp_2015_114
crossref_primary_10_1007_s11756_021_00860_4
crossref_primary_10_3389_fphar_2017_00621
crossref_primary_10_1097_WNR_0b013e32834d2216
crossref_primary_10_1111_gbb_12121
crossref_primary_10_1371_journal_pone_0095997
crossref_primary_10_2147_PGPM_S326885
crossref_primary_10_1016_j_genrep_2022_101677
crossref_primary_10_1016_j_cpr_2016_11_003
crossref_primary_10_1124_mol_111_076604
crossref_primary_10_1038_tp_2012_11
crossref_primary_10_1007_s40200_021_00740_3
crossref_primary_10_1038_s41397_021_00212_0
crossref_primary_10_1111_ahg_12046
crossref_primary_10_1111_ahg_12322
crossref_primary_10_1155_2019_4678969
crossref_primary_10_1371_journal_pone_0097428
crossref_primary_10_1186_gb_2014_15_4_r65
crossref_primary_10_1007_s00439_012_1145_7
Cites_doi 10.1093/nar/17.20.8093
10.1093/bioinformatics/btn564
10.1038/nature06258
10.1093/nar/17.9.3606
10.1074/jbc.M504942200
10.1523/JNEUROSCI.20-22-08305.2000
10.1002/da.20517
10.1146/annurev.pa.33.040193.001433
10.1371/journal.pone.0009348
10.1016/j.pneurobio.2004.05.006
10.1016/S0306-4522(02)00257-9
10.1016/j.pharmthera.2004.11.001
10.1080/14622200410001734030
10.1038/npp.2008.37
10.1093/brain/awn248
10.1146/annurev.neuro.29.051605.113009
10.1002/syn.890140210
10.1097/01.fpc.0000230119.34205.8a
10.2217/14622416.9.9.1285
10.1097/FBP.0b013e3283242f05
10.1007/s00213-005-2223-5
10.1038/sj.mp.4001938
10.1073/pnas.0707106104
10.1523/JNEUROSCI.4858-08.2009
10.1038/mp.2008.30
10.1016/j.neuroscience.2009.04.048
10.1097/YPG.0b013e32833a215a
10.1097/FPC.0b013e328320a3fd
10.1176/appi.ajp.2009.09040598
10.1093/hmg/6.4.577
10.1016/j.pnpbp.2009.08.024
10.2144/03345dd03
10.1038/nrg2063
10.1093/alcalc/agm030
10.1016/j.schres.2004.08.020
10.1038/sj.npp.1300861
10.1038/sj.mp.4001145
10.1016/j.neulet.2006.10.064
10.1007/s12017-008-8051-0
10.1002/ajmg.b.30876
10.1093/hmg/ddg055
10.1016/j.euroneuro.2005.09.004
10.1016/0197-0186(93)90050-F
10.1093/oxfordjournals.molbev.a004023
10.1093/hmg/ddl192
10.1111/j.1471-4159.2006.04186.x
10.1523/JNEUROSCI.3609-09.2009
10.1038/35041572
10.1017/S1461145706007152
10.1073/pnas.95.13.7731
10.1038/ejhg.2008.57
ContentType Journal Article
Copyright American College of Neuropsychopharmacology 2011
2015 INIST-CNRS
Copyright Nature Publishing Group Mar 2011
Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology
Copyright_xml – notice: American College of Neuropsychopharmacology 2011
– notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Mar 2011
– notice: Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PSYQQ
Q9U
7X8
7TM
5PM
DOI 10.1038/npp.2010.208
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Proquest Medical Database
Psychology Database
Biological science database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
Nucleic Acids Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList Neurosciences Abstracts

MEDLINE

MEDLINE - Academic
ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate DRD2 polymorphisms associated with cocaine abuse
EISSN 1740-634X
EndPage 762
ExternalDocumentID PMC3055737
2262511741
21150907
24037436
10_1038_npp_2010_208
Genre Journal Article
Comparative Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: R01 DA022199
– fundername: NIGMS NIH HHS
  grantid: U01 GM092655
GroupedDBID ---
--K
-DZ
-Q-
0R~
1B1
29N
2WC
36B
39C
3V.
4.4
406
53G
5RE
5VS
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AAEDT
AALRI
AANZL
AAQFI
AAQXK
AASML
AATNV
AAXUO
AAYZH
AAZLF
ABAKF
ABIVO
ABJNI
ABLJU
ABMAC
ABUWG
ABWVN
ABZZP
ACAOD
ACGFO
ACGFS
ACIUM
ACKTT
ACMJI
ACPRK
ACRPL
ACRQY
ACZOJ
ADBBV
ADFRT
ADHDB
ADMUD
ADNMO
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
AVWKF
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FEDTE
FERAY
FGOYB
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IHE
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
M2M
M41
M7P
MK0
NADUK
NAO
NQ-
NQJWS
NXXTH
O9-
OK1
P2P
P6G
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
R2-
RIG
RNS
RNT
RNTTT
ROL
RPM
RPZ
SEW
SNX
SNYQT
SOHCF
SOJ
SRMVM
SSZ
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
ZKB
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
ACVFH
ADCNI
AEUPX
AFPUW
AGQPQ
IQODW
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
Q9U
7X8
7TM
5PM
ID FETCH-LOGICAL-c510t-63855e23e702cb020d3682b55c37c8ca8a6a68229837d65dbead5124d72a3a733
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 14:15:04 EDT 2025
Fri Jul 11 05:39:01 EDT 2025
Tue Aug 05 10:01:28 EDT 2025
Fri Jul 25 08:54:29 EDT 2025
Mon Jul 21 06:04:01 EDT 2025
Mon Jul 21 09:17:13 EDT 2025
Tue Jul 01 01:05:19 EDT 2025
Thu Apr 24 23:06:53 EDT 2025
Fri Feb 21 02:38:35 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords alternative splicing
D2S
DRD2
cocaine
dopamine
human
Human
Alternative splicing
Drug addiction
Dopamine
CNS stimulant
Psychotropic
Catecholamine
Ester
D2 Dopamine receptor
Neurotransmitter
Cocaine
Drug of abuse
Polymorphism
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c510t-63855e23e702cb020d3682b55c37c8ca8a6a68229837d65dbead5124d72a3a733
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
OpenAccessLink https://www.nature.com/articles/npp2010208.pdf
PMID 21150907
PQID 850711152
PQPubID 33935
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3055737
proquest_miscellaneous_907156466
proquest_miscellaneous_851476665
proquest_journals_850711152
pubmed_primary_21150907
pascalfrancis_primary_24037436
crossref_citationtrail_10_1038_npp_2010_208
crossref_primary_10_1038_npp_2010_208
springer_journals_10_1038_npp_2010_208
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-03-01
PublicationDateYYYYMMDD 2011-03-01
PublicationDate_xml – month: 03
  year: 2011
  text: 2011-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Basingstoke
– name: England
– name: New York
PublicationSubtitle At the intersection of brain, behavior, and therapeutics
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAbbrev Neuropsychopharmacol
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2011
Publisher Springer International Publishing
Nature Publishing Group
Publisher_xml – name: Springer International Publishing
– name: Nature Publishing Group
References WH Huang (BFnpp2010208_CR17) 2009; 34
A Bertolino (BFnpp2010208_CR4) 2010; 5
A Haliassos (BFnpp2010208_CR14) 1989; 17
CC Zai (BFnpp2010208_CR50) 2007; 10
JK Seamans (BFnpp2010208_CR39) 2004; 74
J Voisey (BFnpp2010208_CR44) 2009; 26
A Usiello (BFnpp2010208_CR43) 2000; 408
G Blasi (BFnpp2010208_CR5) 2009; 29
H Ishiguro (BFnpp2010208_CR21) 1998; 22
ZU Khan (BFnpp2010208_CR25) 1998; 95
Y Zhang (BFnpp2010208_CR52) 2007; 104
R Hwang (BFnpp2010208_CR19) 2006; 16
A Doehring (BFnpp2010208_CR7) 2009; 19
MJ Frank (BFnpp2010208_CR9) 2009; 164
AD Johnson (BFnpp2010208_CR23) 2005; 106
JW Smith (BFnpp2010208_CR40) 2002; 113
YY Wang (BFnpp2010208_CR47) 2000; 20
SE Hyman (BFnpp2010208_CR20) 2006; 29
Y Zhang (BFnpp2010208_CR53) 2005; 280
A Bertolino (BFnpp2010208_CR3) 2009; 132
GA Wray (BFnpp2010208_CR48) 2007; 8
JB Duan (BFnpp2010208_CR8) 2003; 12
MF Gosso (BFnpp2010208_CR13) 2008; 16
ND Volkow (BFnpp2010208_CR45) 1993; 14
SJ Glatt (BFnpp2010208_CR12) 2009; 14
PG Strange (BFnpp2010208_CR41) 1993; 22
B Le Foll (BFnpp2010208_CR28) 2009; 20
UW Preuss (BFnpp2010208_CR36) 2007; 42
MV Rockman (BFnpp2010208_CR37) 2002; 19
BR Lawford (BFnpp2010208_CR27) 2005; 73
MR Munafo (BFnpp2010208_CR32) 2004; 6
D Wang (BFnpp2010208_CR46) 2006; 16
C Lerman (BFnpp2010208_CR29) 2006; 31
ME Lull (BFnpp2010208_CR31) 2008; 1141
I Herzberg (BFnpp2010208_CR16) 2010; 20
AD Johnson (BFnpp2010208_CR24) 2008; 24
JP Zhang (BFnpp2010208_CR51) 2010; 167
R Xu (BFnpp2010208_CR49) 2002; 7
T Sasabe (BFnpp2010208_CR38) 2007; 412
A Haliassos (BFnpp2010208_CR15) 1989; 17
KA Frazer (BFnpp2010208_CR10) 2007; 449
M Lucht (BFnpp2010208_CR30) 2010; 34
XY Jiang (BFnpp2010208_CR22) 2009; 11
O Civelli (BFnpp2010208_CR6) 1993; 33
BK Thelma (BFnpp2010208_CR42) 2008; 9
TP Giordano (BFnpp2010208_CR11) 2006; 99
R Hwang (BFnpp2010208_CR18) 2005; 181
T Arinami (BFnpp2010208_CR1) 1997; 6
JK Pinsonneault (BFnpp2010208_CR35) 2006; 15
SH Kollins (BFnpp2010208_CR26) 2008; 147B
MR Munafo (BFnpp2010208_CR33) 2007; 12
A Bertolino (BFnpp2010208_CR2) 2009; 29
AC Papp (BFnpp2010208_CR34) 2003; 34
8101394 - Synapse. 1993 Jun;14(2):169-77
2573037 - Nucleic Acids Res. 1989 Oct 25;17(20):8093-9
18382477 - Eur J Hum Genet. 2008 Sep;16(9):1075-82
18991951 - Ann N Y Acad Sci. 2008 Oct;1141:58-75
16123753 - Neuropsychopharmacology. 2006 Jan;31(1):231-42
16046395 - J Biol Chem. 2005 Sep 23;280(38):32618-24
17943122 - Nature. 2007 Oct 18;449(7164):851-61
15781120 - Pharmacol Ther. 2005 Apr;106(1):19-38
17304246 - Nat Rev Genet. 2007 Mar;8(3):206-16
16776597 - Annu Rev Neurosci. 2006;29:565-98
17196743 - Neurosci Lett. 2007 Jan 29;412(2):139-42
18077373 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7
17026527 - J Neurochem. 2006 Nov;99(4):1197-206
12476322 - Mol Psychiatry. 2002;7(10):1075-82
18833581 - Depress Anxiety. 2009;26(1):28-33
12411608 - Mol Biol Evol. 2002 Nov;19(11):1991-2004
12765033 - Biotechniques. 2003 May;34(5):1068-72
15830237 - Psychopharmacology (Berl). 2005 Aug;181(1):179-87
8494342 - Annu Rev Pharmacol Toxicol. 1993;33:281-307
19176830 - J Neurosci. 2009 Jan 28;29(4):1224-34
19373123 - Pharmacogenet Genomics. 2009 Jun;19(6):407-14
18946637 - Neuromolecular Med. 2009;11(1):1-12
17453061 - Mol Psychiatry. 2007 May;12(5):454-61
8095172 - Neurochem Int. 1993 Mar;22(3):223-36
18821566 - Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8
12554675 - Hum Mol Genet. 2003 Feb 1;12(3):205-16
16959057 - Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51
18354387 - Neuropsychopharmacology. 2009 Jan;34(2):319-30
17001293 - Pharmacogenet Genomics. 2006 Oct;16(10):735-45
19179847 - Behav Pharmacol. 2009 Feb;20(1):1-17
9660310 - Alcohol Clin Exp Res. 1998 Jun;22(4):845-8
15381316 - Prog Neurobiol. 2004 Sep;74(1):1-58
20179754 - PLoS One. 2010;5(2):e9348
11069937 - J Neurosci. 2000 Nov 15;20(22):8305-14
18332877 - Mol Psychiatry. 2009 Sep;14(9):885-93
19393722 - Neuroscience. 2009 Nov 24;164(1):131-40
20431429 - Psychiatr Genet. 2010 Aug;20(4):179-83
16278074 - Eur Neuropsychopharmacol. 2006 May;16(4):248-59
15370155 - Nicotine Tob Res. 2004 Aug;6(4):583-97
19940176 - J Neurosci. 2009 Nov 25;29(47):14812-9
12182883 - Neuroscience. 2002;113(4):755-65
9097961 - Hum Mol Genet. 1997 Apr;6(4):577-82
18974171 - Bioinformatics. 2008 Dec 15;24(24):2938-9
19796663 - Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):45-9
15567074 - Schizophr Res. 2005 Feb 1;73(1):31-7
9636219 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7731-6
17526637 - Alcohol Alcohol. 2007 May-Jun;42(3):258-66
18781856 - Pharmacogenomics. 2008 Sep;9(9):1285-306
20194480 - Am J Psychiatry. 2010 Jul;167(7):763-72
18829695 - Brain. 2009 Feb;132(Pt 2):417-25
2726503 - Nucleic Acids Res. 1989 May 11;17(9):3606
11089973 - Nature. 2000 Nov 9;408(6809):199-203
16893905 - Hum Mol Genet. 2006 Sep 1;15(17):2636-49
References_xml – volume: 17
  start-page: 8093
  year: 1989
  ident: BFnpp2010208_CR14
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/17.20.8093
– volume: 24
  start-page: 2938
  year: 2008
  ident: BFnpp2010208_CR24
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btn564
– volume: 449
  start-page: 851
  year: 2007
  ident: BFnpp2010208_CR10
  publication-title: Nature
  doi: 10.1038/nature06258
– volume: 17
  start-page: 3606
  year: 1989
  ident: BFnpp2010208_CR15
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/17.9.3606
– volume: 280
  start-page: 32618
  year: 2005
  ident: BFnpp2010208_CR53
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M504942200
– volume: 20
  start-page: 8305
  year: 2000
  ident: BFnpp2010208_CR47
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-22-08305.2000
– volume: 26
  start-page: 28
  year: 2009
  ident: BFnpp2010208_CR44
  publication-title: Depress Anxiety
  doi: 10.1002/da.20517
– volume: 33
  start-page: 281
  year: 1993
  ident: BFnpp2010208_CR6
  publication-title: Ann Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pa.33.040193.001433
– volume: 5
  start-page: e9348
  issue: 2
  year: 2010
  ident: BFnpp2010208_CR4
  publication-title: Plos One
  doi: 10.1371/journal.pone.0009348
– volume: 74
  start-page: 1
  year: 2004
  ident: BFnpp2010208_CR39
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2004.05.006
– volume: 113
  start-page: 755
  year: 2002
  ident: BFnpp2010208_CR40
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(02)00257-9
– volume: 106
  start-page: 19
  year: 2005
  ident: BFnpp2010208_CR23
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2004.11.001
– volume: 6
  start-page: 583
  year: 2004
  ident: BFnpp2010208_CR32
  publication-title: Nicotine Tobacco Res
  doi: 10.1080/14622200410001734030
– volume: 34
  start-page: 319
  year: 2009
  ident: BFnpp2010208_CR17
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2008.37
– volume: 132
  start-page: 417
  year: 2009
  ident: BFnpp2010208_CR3
  publication-title: Brain
  doi: 10.1093/brain/awn248
– volume: 29
  start-page: 565
  year: 2006
  ident: BFnpp2010208_CR20
  publication-title: Ann Rev Neurosci
  doi: 10.1146/annurev.neuro.29.051605.113009
– volume: 14
  start-page: 169
  year: 1993
  ident: BFnpp2010208_CR45
  publication-title: Synapse
  doi: 10.1002/syn.890140210
– volume: 16
  start-page: 735
  year: 2006
  ident: BFnpp2010208_CR46
  publication-title: Pharmacogenetics Genomics
  doi: 10.1097/01.fpc.0000230119.34205.8a
– volume: 1141
  start-page: 58
  year: 2008
  ident: BFnpp2010208_CR31
  publication-title: Addiction Rev
– volume: 9
  start-page: 1285
  year: 2008
  ident: BFnpp2010208_CR42
  publication-title: Pharmacogenomics
  doi: 10.2217/14622416.9.9.1285
– volume: 20
  start-page: 1
  year: 2009
  ident: BFnpp2010208_CR28
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e3283242f05
– volume: 181
  start-page: 179
  year: 2005
  ident: BFnpp2010208_CR18
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-005-2223-5
– volume: 12
  start-page: 454
  year: 2007
  ident: BFnpp2010208_CR33
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001938
– volume: 104
  start-page: 20552
  year: 2007
  ident: BFnpp2010208_CR52
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0707106104
– volume: 29
  start-page: 1224
  year: 2009
  ident: BFnpp2010208_CR2
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.4858-08.2009
– volume: 14
  start-page: 885
  year: 2009
  ident: BFnpp2010208_CR12
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2008.30
– volume: 164
  start-page: 131
  year: 2009
  ident: BFnpp2010208_CR9
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.04.048
– volume: 22
  start-page: 845
  year: 1998
  ident: BFnpp2010208_CR21
  publication-title: Alcohol Clin Exp Res
– volume: 20
  start-page: 179
  year: 2010
  ident: BFnpp2010208_CR16
  publication-title: Psychiatr Genet
  doi: 10.1097/YPG.0b013e32833a215a
– volume: 19
  start-page: 407
  year: 2009
  ident: BFnpp2010208_CR7
  publication-title: Pharmacogenetics Genomics
  doi: 10.1097/FPC.0b013e328320a3fd
– volume: 167
  start-page: 763
  year: 2010
  ident: BFnpp2010208_CR51
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2009.09040598
– volume: 6
  start-page: 577
  year: 1997
  ident: BFnpp2010208_CR1
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/6.4.577
– volume: 34
  start-page: 45
  year: 2010
  ident: BFnpp2010208_CR30
  publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2009.08.024
– volume: 34
  start-page: 1068
  year: 2003
  ident: BFnpp2010208_CR34
  publication-title: Biotechniques
  doi: 10.2144/03345dd03
– volume: 8
  start-page: 206
  year: 2007
  ident: BFnpp2010208_CR48
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg2063
– volume: 42
  start-page: 258
  year: 2007
  ident: BFnpp2010208_CR36
  publication-title: Alcohol Alcohol
  doi: 10.1093/alcalc/agm030
– volume: 73
  start-page: 31
  year: 2005
  ident: BFnpp2010208_CR27
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2004.08.020
– volume: 31
  start-page: 231
  year: 2006
  ident: BFnpp2010208_CR29
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300861
– volume: 7
  start-page: 1075
  year: 2002
  ident: BFnpp2010208_CR49
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001145
– volume: 412
  start-page: 139
  year: 2007
  ident: BFnpp2010208_CR38
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2006.10.064
– volume: 11
  start-page: 1
  year: 2009
  ident: BFnpp2010208_CR22
  publication-title: Neuromol Med
  doi: 10.1007/s12017-008-8051-0
– volume: 147B
  start-page: 1580
  year: 2008
  ident: BFnpp2010208_CR26
  publication-title: Am J Med Genet BNeuropsychiatr Genet
  doi: 10.1002/ajmg.b.30876
– volume: 12
  start-page: 205
  year: 2003
  ident: BFnpp2010208_CR8
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddg055
– volume: 16
  start-page: 248
  year: 2006
  ident: BFnpp2010208_CR19
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2005.09.004
– volume: 22
  start-page: 223
  year: 1993
  ident: BFnpp2010208_CR41
  publication-title: Neurochem Int
  doi: 10.1016/0197-0186(93)90050-F
– volume: 19
  start-page: 1991
  year: 2002
  ident: BFnpp2010208_CR37
  publication-title: Mol Biol Evol
  doi: 10.1093/oxfordjournals.molbev.a004023
– volume: 15
  start-page: 2636
  year: 2006
  ident: BFnpp2010208_CR35
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddl192
– volume: 99
  start-page: 1197
  year: 2006
  ident: BFnpp2010208_CR11
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2006.04186.x
– volume: 29
  start-page: 14812
  year: 2009
  ident: BFnpp2010208_CR5
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3609-09.2009
– volume: 408
  start-page: 199
  year: 2000
  ident: BFnpp2010208_CR43
  publication-title: Nature
  doi: 10.1038/35041572
– volume: 10
  start-page: 639
  year: 2007
  ident: BFnpp2010208_CR50
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145706007152
– volume: 95
  start-page: 7731
  year: 1998
  ident: BFnpp2010208_CR25
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.95.13.7731
– volume: 16
  start-page: 1075
  year: 2008
  ident: BFnpp2010208_CR13
  publication-title: Eur J Hum Genet
  doi: 10.1038/ejhg.2008.57
– reference: 12411608 - Mol Biol Evol. 2002 Nov;19(11):1991-2004
– reference: 18833581 - Depress Anxiety. 2009;26(1):28-33
– reference: 19940176 - J Neurosci. 2009 Nov 25;29(47):14812-9
– reference: 9660310 - Alcohol Clin Exp Res. 1998 Jun;22(4):845-8
– reference: 20179754 - PLoS One. 2010;5(2):e9348
– reference: 16046395 - J Biol Chem. 2005 Sep 23;280(38):32618-24
– reference: 20431429 - Psychiatr Genet. 2010 Aug;20(4):179-83
– reference: 11089973 - Nature. 2000 Nov 9;408(6809):199-203
– reference: 15370155 - Nicotine Tob Res. 2004 Aug;6(4):583-97
– reference: 12476322 - Mol Psychiatry. 2002;7(10):1075-82
– reference: 18781856 - Pharmacogenomics. 2008 Sep;9(9):1285-306
– reference: 19393722 - Neuroscience. 2009 Nov 24;164(1):131-40
– reference: 19179847 - Behav Pharmacol. 2009 Feb;20(1):1-17
– reference: 19176830 - J Neurosci. 2009 Jan 28;29(4):1224-34
– reference: 15830237 - Psychopharmacology (Berl). 2005 Aug;181(1):179-87
– reference: 17196743 - Neurosci Lett. 2007 Jan 29;412(2):139-42
– reference: 18382477 - Eur J Hum Genet. 2008 Sep;16(9):1075-82
– reference: 2726503 - Nucleic Acids Res. 1989 May 11;17(9):3606
– reference: 17453061 - Mol Psychiatry. 2007 May;12(5):454-61
– reference: 16959057 - Int J Neuropsychopharmacol. 2007 Oct;10(5):639-51
– reference: 18354387 - Neuropsychopharmacology. 2009 Jan;34(2):319-30
– reference: 18829695 - Brain. 2009 Feb;132(Pt 2):417-25
– reference: 19796663 - Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):45-9
– reference: 11069937 - J Neurosci. 2000 Nov 15;20(22):8305-14
– reference: 18946637 - Neuromolecular Med. 2009;11(1):1-12
– reference: 17943122 - Nature. 2007 Oct 18;449(7164):851-61
– reference: 8095172 - Neurochem Int. 1993 Mar;22(3):223-36
– reference: 15567074 - Schizophr Res. 2005 Feb 1;73(1):31-7
– reference: 8101394 - Synapse. 1993 Jun;14(2):169-77
– reference: 16123753 - Neuropsychopharmacology. 2006 Jan;31(1):231-42
– reference: 9097961 - Hum Mol Genet. 1997 Apr;6(4):577-82
– reference: 12765033 - Biotechniques. 2003 May;34(5):1068-72
– reference: 9636219 - Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7731-6
– reference: 17026527 - J Neurochem. 2006 Nov;99(4):1197-206
– reference: 17304246 - Nat Rev Genet. 2007 Mar;8(3):206-16
– reference: 18332877 - Mol Psychiatry. 2009 Sep;14(9):885-93
– reference: 19373123 - Pharmacogenet Genomics. 2009 Jun;19(6):407-14
– reference: 15381316 - Prog Neurobiol. 2004 Sep;74(1):1-58
– reference: 16776597 - Annu Rev Neurosci. 2006;29:565-98
– reference: 18991951 - Ann N Y Acad Sci. 2008 Oct;1141:58-75
– reference: 17526637 - Alcohol Alcohol. 2007 May-Jun;42(3):258-66
– reference: 12554675 - Hum Mol Genet. 2003 Feb 1;12(3):205-16
– reference: 8494342 - Annu Rev Pharmacol Toxicol. 1993;33:281-307
– reference: 18974171 - Bioinformatics. 2008 Dec 15;24(24):2938-9
– reference: 16278074 - Eur Neuropsychopharmacol. 2006 May;16(4):248-59
– reference: 18821566 - Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1580-8
– reference: 18077373 - Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20552-7
– reference: 12182883 - Neuroscience. 2002;113(4):755-65
– reference: 17001293 - Pharmacogenet Genomics. 2006 Oct;16(10):735-45
– reference: 16893905 - Hum Mol Genet. 2006 Sep 1;15(17):2636-49
– reference: 15781120 - Pharmacol Ther. 2005 Apr;106(1):19-38
– reference: 2573037 - Nucleic Acids Res. 1989 Oct 25;17(20):8093-9
– reference: 20194480 - Am J Psychiatry. 2010 Jul;167(7):763-72
SSID ssj0015768
Score 2.3837128
Snippet The dopamine receptor D2 (encoded by DRD2 ) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this...
The dopamine receptor D2 (encoded by DRD2) is implicated in susceptibility to mental disorders and cocaine abuse, but mechanisms responsible for this...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 753
SubjectTerms 631/208/2489/144
631/208/726/649
631/337/1645/1946
692/699/476/5
Addictive behaviors
Adult
Adult and adolescent clinical studies
Alternative splicing
Alternative Splicing - genetics
Autopsy
Behavioral Sciences
Biological and medical sciences
Biological Psychology
Brain
Brain - metabolism
Brain - pathology
Cocaine
Cocaine-Related Disorders - genetics
Cocaine-Related Disorders - metabolism
Cocaine-Related Disorders - pathology
Cortex (prefrontal)
Dopamine D2 receptors
Drug abuse
Drug addiction
Exons
Female
Genetic Predisposition to Disease
HEK293 Cells
Humans
Introns
Introns - genetics
Linkage disequilibrium
Male
Medical sciences
Medicine
Medicine & Public Health
Memory
Mental disorders
Middle Aged
mRNA
Neuropharmacology
Neurosciences
Original
original-article
Pharmacology. Drug treatments
Pharmacotherapy
Polymorphism, Single Nucleotide - genetics
Psychiatry
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Putamen
Receptors, Dopamine D2 - biosynthesis
Receptors, Dopamine D2 - genetics
Single-nucleotide polymorphism
Young Adult
Title Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse
URI https://link.springer.com/article/10.1038/npp.2010.208
https://www.ncbi.nlm.nih.gov/pubmed/21150907
https://www.proquest.com/docview/850711152
https://www.proquest.com/docview/851476665
https://www.proquest.com/docview/907156466
https://pubmed.ncbi.nlm.nih.gov/PMC3055737
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFLZgkxASQtBxCYPKD9AXFi2L40ueUNlFA2lTBZvUt8hxXG1SmwTSIvXfc47jpBQ2XvpQn9RuznH8nUu-Q8h7lotUW8nDmZil4KCYPEyTOAkB2oNHFEsVuReFLy7F-XXydcqnvjan8WWV3TPRPaiLymCM_FAhcAH4En-qf4TYNAqTq76DxkOyi8xlaNRy2vtbRwilHYhMWQgTT33de8TUYVnXbVlXjH0l_ziRntS6gZsza7ta3AU7_62e_CuF6k6ms2fkqYeUdNzawHPywJYDsjcuwZ1erOmIuiJPFz0fkEcXPpc-IKNJy1q9PqBXm5ewmgN3Rc9nvd4jqy9l2yiHTqr5elGBZm6bRUPHrhQElkTHcx9W_GXpd0yI45fVjLoMAT0Bv3wBU9KTmAJKtTW4-bBaSzvTsAXFcDA9hnMV5cb5qrEvyPXZ6dXxeei7NYQG9vUyhI3MuY2ZlVFsckChBRMqzjk3TBpltNJCC6SXB5e4ELzIwYYBbSSFjDXTkrGXZKesSvuaUA2ubS4MeGIsShJmcm0SZQxSoyle6CggHzuNZcZTmWNHjXnmUupMZaDfDPULHyogH3rpuqXwuEduuKX8XhgpCwFoiYDsd9aQ-Z3eZL1dBoT2o7BFMe-iS1utUOQokeAm8vtFUvgRLhIBc7xqrWszO2J2GA-I3LK7XgAJwrdHytsbRxSObG6SwZWjzkI3677rDrz57x_cJ4_bgDoW4L0lO8ufK_sOENkyH7p9NyS7n08vJ99-AwCRN3Y
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NQwIkhKDjowyGH1hfWLTMTpz0AaFqZWrZOk2ik_oWHMcVk9okLC2ofxT_I3fORylsvO0lD_EldnJn-3535zuAdyKWXWUC35nKaRcBio6drsc9B1V7REQ8CF17UHh0LgeX3ueJP9mCX_VZGAqrrNdEu1AnmSYb-WFIiguqL_xj_t2holHkXK0raJRScWpWPxGxFR-GfWTvPucnn8bHA6cqKuBoFL-Fg_Lm-4YLE7hcx6gsJUKGPPZ9LQIdahUqqSRlQUfklkg_ifFX46boJQFXQgVk_8QV_x7uuy5hvWDS4LsjUt2t0toVDn7opIqzd0V4mOZ5GUbGqY7lHzvgo1wVyIxpWUXjJjX332jNv1y2dic8eQKPKxWW9UqZewpbJm3BTi9F-D5fsQ6zQaXWWt-C-6PKd9-CzkWZJXt1wMbrQ1_FgX2iyZ-92oHlMC0L87CLbLaaZygJV8W8YD0beoJDYr1ZZcb8YdgXcsDTzWzKrEeC9bNczbFL1ucMtWKTL7JrHK1htSiahJH5mR3jPk50vXhZmGdweSeMfA7baZaal8AUQulYakR-wvU8oWOlvVBrSsUW-oly2_C-5likq9TpVMFjFlkXvggj5G9E_MVL2Ib9hjovU4bcQre3wfyGmFIkomIn27BbS0NUrSxF1MyDNrCmFZcE8vOo1GRLIjnyAoSl_u0kXXyJLz2JfbwopWvdO2EEbG9DsCF3DQElJN9sSa--2cTklD0uEPhkp5bQ9bhv-gOv_vuBb-HBYDw6i86G56e78LA05lPw32vYXlwvzRvUBhfxnp2DDL7e9aT_DeIycT8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NnTQhIQQdH2Uw_MD6wqIVO3HSB4TKumplrKpgk_oWHMcVk9okLC2ofxr_HXfORylsvO0lD_EldnJn-3cfvgN4LSLZVcb3nKmcdlFB0ZHTdbnrILRHjYj7QcceFD4fydNL9-PEm2zBr-osDIVVVmuiXajjVJON_Cgg4ILwhR9Ny6iIcX_wPvvuUAEpcrRW1TQKCTkzq5-oveXvhn1k9QHng5OL41OnLDDgaBTFhYOy53mGC-N3uI4QOMVCBjzyPC18HWgVKKkkZURHLS6WXhzhb8cN0o19roTyyRaKq_-2T0pRA7Y_nIzGn2sXBgF5C2G7wsHPnpRR9x0RHCVZVgSVcapq-cd-eD9TObJmWtTUuAn0_hu7-ZcD1-6Lg4fwoAS0rFdI4CPYMkkTdnsJKvPzFWszG2JqbfdN2DkvPflNaI-LnNmrQ3axPgKWH9on6mzaq11YDpOiTA8bp7PVPEW5uMrnOevZQBQcEuvNSqPmD8O-kDuebqZTZv0TrJ9mao5dsj5niJFNtkivcbSGVYJpYkbGaHaMuzrR9aJlbh7D5Z2w8gk0kjQxz4ApVKwjqVEPFB3XFTpS2g20psRsgRerTgveVBwLdZlInep5zELr0BdBiPwNib94CVpwUFNnRQKRW-j2N5hfE1PCRIR5sgV7lTSE5TqTh_WsaAGrW3GBIK-PSky6JJK3ro9Kqnc7SRdf4klXYh9PC-la904aA7a3wN-Qu5qA0pNvtiRX32yacsol5wt8sl1J6HrcN_2B5__9wFewgxM-_DQcne3BvcKyT5GAL6CxuF6alwgNF9F-OQkZfL3ref8bca122g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intronic+Polymorphisms+Affecting+Alternative+Splicing+of+Human+Dopamine+D2+Receptor+Are+Associated+with+Cocaine+Abuse&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Moyer%2C+Robert+A&rft.au=Wang%2C+Danxin&rft.au=Papp%2C+Audrey+C&rft.au=Smith%2C+Ryan+M&rft.date=2011-03-01&rft.issn=0893-133X&rft.volume=36&rft.issue=4&rft.spage=753&rft.epage=762&rft_id=info:doi/10.1038%2Fnpp.2010.208&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon